Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.
about
Dengue Virus Evolution and Virulence ModelsSpecific capture and whole-genome sequencing of viruses from clinical samplesVaricella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesvirusesVaricella-zoster vaccine virus: evolution in action.Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zosterA varicella-zoster virus mutant impaired for latency in rodents, but not impaired for replication in cell cultureSevere complications of chickenpox in hospitalised children in the UK and Ireland.Mutational analysis of varicella-zoster virus (VZV) immediate early protein (IE62) subdomains and their importance in viral replication.Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.Molecular studies of the Oka varicella vaccine.Clinical and molecular aspects of the live attenuated Oka varicella vaccine.Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.Population diversity in batches of the varicella Oka vaccineTransmission of varicella vaccine virus, JapanComplete DNA sequences of two oka strain varicella-zoster virus genomes.Varicella and herpes zoster vaccine development: lessons learned.Herpes Zoster: New Insights Provide an Important Wake‐Up Call for Management of Nosocomial Transmission
P2860
Q27485628-69A4470D-8D2B-4DE5-9BB5-008CBFFADEC0Q28742542-E9A4FC62-323A-439E-92DE-D880A39431BEQ34120083-C126B792-9D45-45EB-B360-D9BE2EBEE6EFQ35576069-5D7B2758-8BFC-43E4-B184-74EC054AB20FQ35942988-E3DA081A-7B0F-4EFF-A9D3-40C69A0EAFF1Q36099431-3375082C-F58F-496E-ADF5-B6B73E551F17Q36121533-2C575763-595F-4EE2-9639-55C68A7B2514Q36784535-5C58C33E-DB5A-420F-A56E-FDA767B78A70Q37532874-6C802761-9343-4E05-B039-F92B27A29CD8Q37932527-5C705697-84FB-492D-BDAE-86B94009B23AQ38200971-6A4AE401-45EC-49E4-B03B-84C30E86FC27Q41857926-597CBCBC-B5EA-4187-B426-32E4F9626127Q42292725-FEEC3E00-E3BD-4445-8963-29EBFF28F173Q42789434-D8A1C171-F19F-47EC-9724-13FE5BBD40A1Q43251025-B9AC9BE8-E96E-4CBB-B38E-807BEFDEE533Q47607699-3B386F4E-3F86-4A6C-BC02-DE8DBB8F9175Q56768036-313E32B0-70B4-45DE-89AE-2679A9778369
P2860
Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Natural selection for rash-for ...... within immunized human hosts.
@ast
Natural selection for rash-for ...... within immunized human hosts.
@en
type
label
Natural selection for rash-for ...... within immunized human hosts.
@ast
Natural selection for rash-for ...... within immunized human hosts.
@en
prefLabel
Natural selection for rash-for ...... within immunized human hosts.
@ast
Natural selection for rash-for ...... within immunized human hosts.
@en
P2093
P2860
P356
P1476
Natural selection for rash-for ...... within immunized human hosts.
@en
P2093
Anne A Gershon
Mahmoud M Al Bassam
Mark L Quinlivan
Philip LaRussa
Sharon P Steinberg
P2860
P304
P356
10.1073/PNAS.0605688104
P407
P577
2006-12-20T00:00:00Z